Merck KGaA Sponsored ADR logo

Merck KGaA Sponsored ADR (MKKGY)

Market Open
12 Jun, 14:56
OTC PINK OTC PINK
$
31. 08
-0.7
-2.2074%
$
68.13B Market Cap
22.51 P/E Ratio
0.47% Div Yield
1,938 Volume
5.79 Eps
$ 31.78
Previous Close
Investors:
Add Transaction
Day Range
30.94 31.2
Year Range
23.73 32.48
Want to track MKKGY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript

Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript

Merck KGaA (MKKGY) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 weeks ago
Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript

Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript

Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript

Seekingalpha | 3 months ago
MKKGY or MDGL: Which Is the Better Value Stock Right Now?

MKKGY or MDGL: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Drugs sector might want to consider either Merck KGaA (MKKGY) or Madrigal (MDGL). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 4 months ago
Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 4 months ago
Merck KGaA (MKKGY) Q3 2025 Earnings Call Transcript

Merck KGaA (MKKGY) Q3 2025 Earnings Call Transcript

Merck KGaA (OTCPK:MKKGY) Q3 2025 Earnings Call November 13, 2025 8:00 AM EST Company Participants Florian Schraeder - Head of Investor Relations Belén Garijo López - Chair of Executive Board & CEO Helene von Roeder - CFO & Member of Executive Board Danny Bar-Zohar - Member of the Executive Board & CEO of Healthcare Kai Beckmann - Deputy CEO of Electronics & Member of the Executive Board Jean Wirth - Member of the Executive Board & CEO Life Science Conference Call Participants Matthew Weston - UBS Investment Bank, Research Division Richard Vosser - JPMorgan Chase & Co, Research Division Shyam Kotadia - Goldman Sachs Group, Inc., Research Division Charles Pitman - Barclays Bank PLC, Research Division Peter Verdult - BNP Paribas, Research Division Oliver Metzger - ODDO BHF Corporate & Markets, Research Division Florent Cespedes - Sanford C. Bernstein & Co., LLC.

Seekingalpha | 7 months ago
MKKGY vs. UTHR: Which Stock Is the Better Value Option?

MKKGY vs. UTHR: Which Stock Is the Better Value Option?

Investors interested in Medical - Drugs stocks are likely familiar with Merck KGaA (MKKGY) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors?

Zacks | 7 months ago
MKKGY or STVN: Which Is the Better Value Stock Right Now?

MKKGY or STVN: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Drugs stocks are likely familiar with Merck KGaA (MKKGY) and Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 10 months ago
MKKGY vs. ZTS: Which Stock Is the Better Value Option?

MKKGY vs. ZTS: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Drugs sector have probably already heard of Merck KGaA (MKKGY) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 year ago
Is Merck KGaA (MKKGY) Stock Undervalued Right Now?

Is Merck KGaA (MKKGY) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Is Merck KGaA (MKKGY) a Great Value Stock Right Now?

Is Merck KGaA (MKKGY) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago